about
Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainRationalizing the development of live attenuated virus vaccinesArchaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses.Oral vaccination: where we are?Mucosal immunization against respiratory bacterial pathogens.Application of Quillaja saponaria extracts as oral adjuvants for plant-made vaccines.Antigen delivery systems.Allergy vaccines--new approaches to an old concept.Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines.Peptide-based vaccines for cancer: realizing their potential.The ABC of clinical and experimental adjuvants--a brief overview.Induction of antibody response in the oral cavity of dogs following intraocular (eye drop) immunization with Porphyromonas gingivalis cell lysate incorporated in pH-sensitive fusogenic polymer-modified liposomes.Topical immunization strategies.Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Liposome-based delivery system for vaccine candidates: constructing an effective formulation.Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications.Gold nanoparticles and vaccine development.Optimization of a Method to Prepare Liposomes Containing HER2/Neu- Derived Peptide as a Vaccine Delivery System for Breast Cancer.Physical properties and biological interactions of liposomes developed as a drug carrier in the field of regenerative medicine.Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapyBiodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing.Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research.Novel Injectable Pentablock Copolymer Based Thermoresponsive Hydrogels for Sustained Release Vaccines.Liposome technology for industrial purposes.A comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by lipid-film hydration and dialysis.Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens.Immunization without needles.Vaccine adjuvants: smart components to boost the immune system.Efficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier.Effect of incorporation of the adjuvant Quil A on structure and immune stimulatory capacity of liposomes
P2860
Q30411506-2D826559-E847-4754-93BE-036C0A660BBCQ34119676-DBBCB3F7-523A-463A-AB0C-3B244BAA9B44Q34557185-EC1FADD6-CB77-46F3-95D8-D6AE3EBCD96EQ34660422-50B6CB41-95F2-49CF-9796-589AFA8F0FF6Q35623339-F30861DB-B633-4BFD-B3A2-4B76D46DB6CEQ35790886-C3B8E460-0C00-4A27-9638-1C3B4796BBD7Q35843648-B39ED41D-E30E-4A21-B414-08F78E8806AFQ35873779-8D637403-D9BE-4CD6-AD70-80F414DD8D3AQ36009558-54C9FDBD-A8EE-4CCB-91DF-B5BB545C7A54Q36968280-7B667FAC-01C7-4D8C-9AA6-A9F003267DDAQ37340462-9F47633D-FA64-466F-8905-FD1F99FFD9E2Q37628867-C219F450-80B8-49C1-ADA5-75DA1617FFECQ37667555-D30937C6-73ED-47B3-8228-7FC77FB6BB67Q37791415-7C8374B0-72CD-4FD1-A4DA-A0DA459FDAEBQ37792984-8982D672-782F-4094-963A-E37CFE7C2DE7Q38068245-402DE626-38F1-41DC-9730-FD5C9EFA9D94Q38113269-2C20C48B-D90E-46F4-A49A-E16402350CF4Q38543673-922CAF1C-40DA-4677-9894-05F108499903Q38627817-6C2E2ECC-C195-4AD4-8791-82D83A853563Q39032416-0E2558B8-30AE-497C-A5FC-CC544D6CBC99Q39568256-622A5FD1-1DE8-4294-9ECC-B4A5E0E706ABQ40043641-294A30F9-7120-4858-BA2B-234E77BF99F1Q40752357-2C0D5CDA-B96E-411C-AE9A-B848210C2D43Q41986626-EF15A0D2-C1E3-442B-AAA6-D60AF9A403D5Q42705145-10279F66-F417-4764-A74F-96E5C2235B68Q44895282-0F5AC0BC-09F5-46B1-8CEE-C4A194ADC927Q45098418-51B1DAE2-1071-4826-8951-1C83A8974733Q46308392-9509697E-3BE9-439E-B958-B0CAF1AD1933Q50063256-6E4E9126-A4A7-4F6E-9BB3-6F38C8CB6808Q53119249-1D4B2461-90C1-448F-A999-701A30F00DEAQ59235261-EF7B675C-9897-4090-89AF-5C42D7362AD8
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Liposomes and ISCOMs.
@ast
Liposomes and ISCOMs.
@en
type
label
Liposomes and ISCOMs.
@ast
Liposomes and ISCOMs.
@en
prefLabel
Liposomes and ISCOMs.
@ast
Liposomes and ISCOMs.
@en
P1433
P1476
Liposomes and ISCOMs.
@en
P2093
Daan J A Crommelin
Gideon F A Kersten
P304
P356
10.1016/S0264-410X(02)00540-6
P407
P577
2003-02-01T00:00:00Z